Johnson & Johnson
Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%
Johnson & Johnson Specialty Surgery [reported separately through FY2019Q4] by Quarter
Specialty Surgery [reported separately through FY2019Q4] — Worldwide sales ($M) ($M)
Johnson & Johnson Specialty Surgery [reported separately through FY2019Q4]: $195M in Q4 2019, down 44.4% from a year earlier. That is the lowest of the 13 quarters on record here. No newer figure appears in the documents we track.
Where the Q4 2019 figure comes from
Calculated from reported figures: Q4 = full year (10-K) − nine months (10-Q)
Source: Form 10-K (filed 2020-02-18) ↗
Reported in Form 10-Q / 10-K Segment Note & Form 8-K EX-99.2 Segment Sales Schedule.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Specialty Surgery [reported separately through FY2019Q4] — Worldwide sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q4 2019 | Dec 29, 2019 | 195 | -44.4% | Form 10-K (filed 2020-02-18) ↗ |
| Q3 2019 | Sep 29, 2019 | 200 | -37.5% | Form 10-Q (filed 2019-10-28) ↗ |
| Q2 2019 | Jun 30, 2019 | 206 | -39.6% | Form 10-Q (filed 2019-07-29) ↗ |
| Q1 2019 | Mar 31, 2019 | 325 | -1.5% | Form 10-Q (filed 2019-05-01) ↗ |
| Q4 2018 | Dec 30, 2018 | 351 | -3.8% | Form 10-K (filed 2019-02-20) ↗ |
| Q3 2018 | Sep 30, 2018 | 320 | +0.6% | Form 10-Q (filed 2018-10-31) ↗ |
| Q2 2018 | Jul 1, 2018 | 341 | +1.2% | Form 10-Q (filed 2018-08-02) ↗ |
| Q1 2018 | Apr 1, 2018 | 330 | +3.1% | Form 10-Q (filed 2019-05-01) ↗ |
| Q4 2017 | Dec 31, 2017 | 365 | -3.2% | Form 10-K (filed 2019-02-20) ↗ |
| Q3 2017 | Oct 1, 2017 | 318 | – | Form 10-Q (filed 2018-10-31) ↗ |
| Q2 2017 | Jul 2, 2017 | 337 | – | Form 10-Q (filed 2018-08-02) ↗ |
| Q1 2017 | Apr 2, 2017 | 320 | – | Form 10-Q (filed 2018-05-01) ↗ |
| Q4 2016 | Jan 1, 2017 | 377 | – | Form 8-K (a8k2017q4exhibit9915.htm, filed 2018-01-23) ↗ |
Breakdown
What makes up specialty Surgery [reported separately through FY2019Q4]
- Specialty Surgery [reported separately through FY2019Q4] — U.S. sales ($M)83 · Q4 2019
- Specialty Surgery [reported separately through FY2019Q4] — International sales ($M)114 · Q4 2019
- Specialty Surgery [reported separately through FY2019Q4] — Worldwide reported growth YoY (%)-44.4% · Q4 2019
- Specialty Surgery [reported separately through FY2019Q4] — Worldwide operational (constant-currency) growth YoY (%)-43.6% · Q4 2019
Cite this data
StockData. (2026). Johnson & Johnson Specialty Surgery [reported separately through FY2019Q4] ($M), quarterly Q4 2016–Q4 2019 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/mt-surg-specialty
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.